Cargando…

Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts

INTRODUCTION: The rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis. Identifying baseline reactogenicity signatures can advance personalized vaccinology and incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez Dias Carvalho, Patrícia Conceição, Dominguez Crespo Hirata, Thiago, Mano Alves, Leandro Yukio, Moscardini, Isabelle Franco, do Nascimento, Ana Paula Barbosa, Costa-Martins, André G., Sorgi, Sara, Harandi, Ali M., Ferreira, Daniela M., Vianello, Eleonora, Haks, Mariëlle C., Ottenhoff, Tom H. M., Santoro, Francesco, Martinez-Murillo, Paola, Huttner, Angela, Siegrist, Claire-Anne, Medaglini, Donata, Nakaya, Helder I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663260/ https://www.ncbi.nlm.nih.gov/pubmed/38022684 http://dx.doi.org/10.3389/fimmu.2023.1259197

Ejemplares similares

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
por: Vianello, Eleonora, et al.
Publicado: (2022)

Methods for predicting vaccine immunogenicity and reactogenicity
por: Gonzalez-Dias, Patrícia, et al.
Publicado: (2019)

Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination
por: Pejoski, David, et al.
Publicado: (2020)

Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination
por: Pejoski, David, et al.
Publicado: (2020)

Host‐directed therapy to combat mycobacterial infections
por: Kilinç, Gül, et al.
Publicado: (2021)

Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis
por: Moscardini, Isabelle Franco, et al.
Publicado: (2022)

Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood
por: Persson, Josefine, et al.
Publicado: (2022)

The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019)

Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey
por: Dayer, Julie-Anne, et al.
Publicado: (2017)

Single-cell analysis reveals chemokine-mediated differential regulation of monocyte mechanics
por: Evers, Tom M.J., et al.
Publicado: (2021)

Human CD8(+) T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset
por: van Meijgaarden, Krista E., et al.
Publicado: (2015)

Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults
por: Weinberger, Birgit, et al.
Publicado: (2018)

Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
por: Ciabattini, Annalisa, et al.
Publicado: (2020)

Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics
por: Vrieling, Frank, et al.
Publicado: (2020)

Ebola virus–like particles reprogram cellular metabolism
por: Tang, Huaqi, et al.
Publicado: (2023)

COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
por: Briggs, Farren Basil Shaw, et al.
Publicado: (2021)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
por: Fratzke, Alycia P., et al.
Publicado: (2022)

CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines
por: Ciabattini, Annalisa, et al.
Publicado: (2013)

Editorial: Advanced Immunization Technologies for Next Generation Vaccines
por: Medaglini, Donata, et al.
Publicado: (2020)

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
por: Pettini, Elena, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
por: Motta, Edwiges, et al.
Publicado: (2023)

Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts
por: Gebremicael, Gebremedhin, et al.
Publicado: (2019)

Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians
por: Majumder, Md. Anwarul Azim, et al.
Publicado: (2022)

Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021)

Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
por: Sivakumaran, Dhanasekaran, et al.
Publicado: (2020)

Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium
por: Kilinç, Gül, et al.
Publicado: (2022)

In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines
por: Molenaar-de Backer, Marijke W. A., et al.
Publicado: (2023)

Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines
por: Lewis, David J. M., et al.
Publicado: (2015)

Reactogenicity to COVID-19 vaccination in the United States of America
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
por: Gonen, Tal, et al.
Publicado: (2023)

Editorial: Non-reactogenic vaccines against Q-fever
por: Gregory, Anthony E., et al.
Publicado: (2023)

Role of the Microbiota in the Modulation of Vaccine Immune Responses
por: Ciabattini, Annalisa, et al.
Publicado: (2019)

From Bivariate to Multivariate Analysis of Cytometric Data: Overview of Computational Methods and Their Application in Vaccination Studies
por: Lucchesi, Simone, et al.
Publicado: (2020)

Whole-blood transcriptomic signatures induced during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites
por: Tran, Tuan M., et al.
Publicado: (2019)

Standardized guinea pig model for Q fever vaccine reactogenicity
por: Baeten, Laurie A., et al.
Publicado: (2018)

Can reactogenicity predict immunogenicity after COVID-19 vaccination?
por: Hwang, Young Hoon, et al.
Publicado: (2021)

Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
por: Das, Swarnali, et al.
Publicado: (2022)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mcj4gbcltcb5fvaulhlmimnqnj